Clinical trial · Observational
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating the Quality of Diet in Allogeneic and Autologous Hematopoietic Stem Cell Transplant Survivors
NCT03377010CI-TRIAL-00040645completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a single center, cross-sectional, non-interventional study aimed at the nutritional intake of long-term health of allogeneic or autologous hematopoietic stem cell transplant (HSCT) survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dietary intake -Food Frequency Questionnaire | Other | — | UNRESOLVED |
| Receptivity to Participating in Diet Interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Hematopoietic Stem Cell Transplant (HSCT) Survivor
- description
- Study participants will be administered a Dietary Intake - Food Frequency Questionnaire and a Receptivity to Participating in Diet Interventions Questionnaire.
- interventionNames
- Other: Dietary intake -Food Frequency Questionnaire
- Other: Receptivity to Participating in Diet Interventions
Primary outcomes (1)
- measure
- Diet intake
- timeFrame
- 1 month
- description
- To evaluate the diet intake of long-term survivors of HSCT
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * Written informed consent obtained from the subject and the ability for the subject to comply with all the study-related procedures for subjects enrolled from the cancer registry. * Both males and females ≥ 18 years of age. * A medical history of allogeneic or autologous hematopoietic stem cell transplant (HSCT), irrespective of the disease. For the purpose of this study, HSCT survivor is defined as subjects one or more years after allogeneic or autologous HSCT without disease relapse, active graft-versus-host disease, or active infection. Subjects with chronic graft versus host disease who are on stable dose of immunosuppressant (or being tapered off of immunosuppressant) over the past 3 months will be eligible. * Study participants must have the ability to complete the questionnaires through one of the previously stated mechanisms. * English speaking due to the logistics of the questionnaires and phone contact included in this study. Exclusion Criteria: * Subjects demonstrating an inability to comply with the study procedures.
References
Publications (0)
Data not yet available
No reference posted for this study.